Fetal sex chromosome testing by maternal plasma DNA sequencing: Clinical laboratory experience and biology

Obstetrics and Gynecology

Volumn 125, Issue 2, 2015, Pages 375-382

  Bianchi, Diana W ^a   Parsa, Saba ^a   Bhatt, Sucheta ^a   Halks Miller, Meredith ^a   Kurtzman, Kathryn ^a   Sehnert, Amy J ^a   Swanson, Amy ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADOLESCENT; ADULT; AMBIGUOUS GENITALIA; ARTICLE; CLINICAL LABORATORY; CONTROLLED STUDY; DNA SEQUENCE; FALSE POSITIVE RESULT; FEMALE; FETUS; HUMAN; KARYOTYPE 46,XX; KARYOTYPE 46,XY; KARYOTYPE 47,XXX; KIDNEY GRAFT; MAJOR CLINICAL STUDY; MATERNAL AGE; MATERNAL PLASMA; MONOSOMY X; MONOSOMY XXX; MONOSOMY XXY; MONOSOMY XYY; NON INVASIVE PROCEDURE; PRENATAL CARE; PRIORITY JOURNAL; SEX CHROMOSOME; SEX CHROMOSOME ABERRATION; MATERNAL SERUM SCREENING TEST; PREGNANCY; SEX DETERMINATION; STATISTICS AND NUMERICAL DATA;

FEMALE; HUMANS; MATERNAL SERUM SCREENING TESTS; PREGNANCY; SEQUENCE ANALYSIS, DNA; SEX CHROMOSOME ABERRATIONS; SEX CHROMOSOMES; SEX DETERMINATION ANALYSIS;

EID: 84922478203     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0000000000000637     Document Type: Article

References (30)

1. Bianchi DW, Wilkins-Haug L. Integration of noninvasive DNA testing for aneuploidy into prenatal care: what has happened since the rubber met the road? Clin Chem 2014; 60: 78-87
2. Scheffer PG, van der Schoot CE, Page-Christiaens GC, Bossers B, van Erp F, de Haas M. Reliability of fetal sex determination using maternal plasma. Obstet Gynecol 2010; 115: 117-26
3. Hill M, Lewis C, Jenkins L, Allen S, Elles RG, Chitty LS. Implementing noninvasive prenatal fetal sex determination using cell-free fetal DNA in the United Kingdom. Expert Opin Biol Ther 2012; 12(suppl 1): S119-26
4. Devaney SA, Palomaki GE, Scott JA, Bianchi DW. Noninvasive fetal sex determination using cell-free fetal DNA: a systematic review and meta-Analysis. JAMA 2011; 306: 627-36
5. Sehnert AJ, Rhees B, Comstock D, de Feo E, Heilek G, Burke J, et al. Optimal detection of fetal chromosomal abnormalities by massively parallel sequencing of cell-free fetal DNA from maternal blood. Clin Chem 2011; 57: 1042-9
6. Bianchi DW, Prosen T, Platt LD, Goldberg JD, Abuhamad AZ, Rava RP, et al. Massively parallel sequencing of maternal plasma DNA in 113 cases of fetal nuchal cystic hygroma. Obstet Gynecol 2013; 121: 1057-62
7. Bianchi DW, Platt LD, Goldberg JD, Abuhamad AZ, Sehnert AJ, Rava RP. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol 2012; 119: 890-901. Erratum in Obstet Gynecol 2012; 120: 957
8. Hooks J, Wolfberg AJ, Wang ET, Struble CA, Zahn J, Juneau K, et al. Non-invasive risk assessment of fetal sex chromosome aneuploidy through directed analysis and incorporation of fetal fraction. Prenat Diagn 2014; 34: 496-9
9. Mazloom AR, DźakuláZ, Oeth P, Wang H, Jensen T, Tynan J, et al. Noninvasive prenatal detection of sex chromosomal aneuploidies by sequencing circulating cell-free DNA from maternal plasma. Prenat Diagn 2013; 33: 591-7
10. Obstetrix Collaborative Research Network, Porreco RP, Garite TJ, Maurel K, Marusiak B, Ehrich M, et al. Noninvasive prenatal screening for fetal trisomies 21, 18, 13 and the common sex chromosome aneuploidies from maternal blood using massively parallel genomic sequencing of DNA. Am J Obstet Gynecol 2014; 211: 365.e1-12
11. Samango-Sprouse C, Banjevic M, Ryan A, Sigurjonsson S, Zimmermann B, Hill M, et al. SNP-based non-invasive prenatal testing detects sex chromosome aneuploidies with high accuracy. Prenat Diagn 2013; 33: 643-9
12. Nicolaides KH, Musci TJ, Struble CA, Syngelaki A, Gil MM. Assessment of fetal sex chromosome aneuploidy using directed cell-free DNA analysis. Fetal Diagn Ther 2014; 35: 1-6
13. Song Y, Liu C, Qi H, Zhang Y, Bian X, Liu J. Noninvasive prenatal testing of fetal aneuploidies by massively parallel sequencing in a prospective Chinese population. Prenat Diagn 2013; 33: 700-6
14. Jiang F, Ren J, Chen F, Zhou Y, Xie J, Dan S, et al. Noninvasive Fetal Trisomy (NIFTY) test: an advanced noninvasive prenatal diagnosis methodology for fetal autosomal and sex chromosome aneuploidies. BMC Med Genomics 2012; 5: 57
15. Guex N, Iseli C, Syngelaki A, Deluen C, Pescia G, Nicolaides KH, et al A robust second-generation genome-wide test for fetal aneuploidy based on shotgun sequencing cell-free DNA in maternal blood. Prenat Diagn 2013; 33: 707-10
16. Hook EB, Warburton D. Turner syndrome revisited: review of new data supports the hypothesis that all viable 45, X cases are cryptic mosaics with a rescue cell line, implying an origin by mitotic loss. Hum Genet 2014; 133: 417-24
17. Boyd PA, Loane M, Garne E, Khoshnood B, Dolk H; EUROCAT working group. Sex chromosome trisomies in Europe: prevalence, prenatal detection and outcome of pregnancy. Eur J Hum Genet 2011; 19: 231-4
18. Futch T, Spinosa J, Bhatt S, de Feo E, Rava RP, Sehnert AJ. Initial clinical laboratory experience in noninvasive prenatal testing for fetal aneuploidy from maternal plasma DNA samples. Prenat Diagn 2013; 33: 569-74
19. Yao H, Jiang F, Hu H, Gao Y, Zhu Z, Zhang H, et al. Detection of fetal sex chromosome aneuploidy by massively parallel sequencing of maternal plasma DNA: initial experience in a Chinese hospital. Ultrasound Obstet Gynecol 2014; 44: 17-24
20. Gil MM, Akolekar R, Quezada MS, Bregant B, Nicolaides KH. Analysis of cell-free DNA in maternal blood screening for aneuploidies: meta-Analysis. Fetal Diagn Ther 2014; 35: 156-73
21. Noninvasive prenatal testing for fetal aneuploidy. Committee Opinion No. 545. American College of Obstetricians and Gynecologists. Obstet Gynecol 2012; 120: 1532-4
22. Benn P, Borell A, Chiu R, Cuckle H, Dugoff L, Faas B, et al. Position statement from the Aneuploidy Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis. Prenat Diagn 2013; 33: 622-9
23. Devers PL, Cronister A, Ormond KE, Facio F, Brasington CK, Flodman P. Noninvasive prenatal testing/noninvasive prenatal diagnosis: the position of the National Society of Genetic Counselors. J Genet Couns 2013; 22: 291-5
24. Gregg AR, Gross SJ, Best RG, Monaghan KG, Bajaj K, Skotko BG, et al. ACMG statement on noninvasive prenatal screening for fetal aneuploidy. Genet Med 2013; 15: 395-8
25. Russell LM, Strike P, Browne CE, Jacobs PA. X chromosome loss and ageing. Cytogenet Genome Res 2007; 116: 181-5
26. Wang Y, Chen Y, Tian F, Zhang J, Song Z, Wu Y, et al. Maternal mosaicism is a significant contributor to discordant sex chromosomal aneuploidies associated with noninvasive prenatal testing. Clin Chem 2014; 60: 251-9
27. McNamara CJ, Limone LA, Westover T, Miller RC. Maternal source of false-positive fetal sex chromosome aneuploidy in noninvasive prenatal testing. Obstet Gynecol 2014; 123(suppl 1): 69S-70S
28. Grati FR, Malvestiti F, Ferreira JC, Bajaj K, Gaetani E, Agrati C, et al. Fetoplacental mosaicism: potential implications for false-positive and false-negative noninvasive prenatal screening results. Genet Med 2014; 16: 620-4
29. Martin JA, Osterman MJ; Centers for Disease Control and Prevention (CDC). Preterm births-United States, 2006 and 2010. MMWR Surveill Summ 2013; 62(suppl 3): 136-8
30. Snyder TM, Khush KK, Valantine HA, Quake SR. Universal noninvasive detection of solid organ transplant rejection. Proc Natl Acad Sci U S A 2011; 108: 6229-34